supported by the Natural Science Foundation of Hainan Province High-level Talent Project(grant number 820RC644);Innovative Research Projects for Postgraduate Students at Hainan Medical University(grant number HYYS2022B08).
Objective:To explore whether thrombopoietin can exert a protective effect against doxorubicin-induced cardiotoxicity by modulating the sirtuin 1(SIRT1)signaling pathway.Methods:H9c2 cell viability was determined by CC...
supported by grants from the Shenkang Municipal Hospital emerging Frontier technology joint project(grant no.SHDC12019131);the National Natural Science Foundation of China(grant no.82202423);the Clinical Research Innovation Plan of Shanghai General Hospital(grant no.CCTR-2022B04);the 3rd Sansheng TCP Young and Middleaged Scientific Research Funding;Shanghai Jiao Tong University“Medicine-Engineering Interdisciplinary Research Fund”(grant no.YG2021QN79);National Key Clinical Specialist Construction Project(grant no.Z155080000004);Shanghai Committee(grant no.23Y31900100).
Background To evaluate the effect of recombinant human thrombopoietin(rhTPO)on clinical prognosis by exploring changes in endothelial cell injury markers and inflammatory factors in patients with sepsis after treatmen...
All procedures involving animals were reviewed and approved by the Tianjin Tiancheng New Drug Evaluation Co.,Ltd(Approval No.2023041701).
BACKGROUND During cirrhosis,the liver is impaired and unable to synthesize and clear thrombopoietin properly.At the same time,the spleen assumes the function of hemofiltration and storage due to liver dysfunction,resu...
supported by the National Key Research and Development Program of China(No.2020YFC2002706);the Army Health Care Special Project(No.19BJZ28).
Immune thrombocytopenia(ITP)is common in the elderly.Because of the coexistence of multiple diseases,there are many reservations regarding corticosteroid use in the elderly.Thrombopoietin(TPO)and its analogs can promo...
Beijing Natural Science Foundation(No.H2018206423);National Natural Science Foundation of China(No.81970113);Key Program of National Natural Science Foundation of China(No.81730004);National Key Research and Development Program of China(No.2017YFA0105503)。
Background:Recombinant human thrombopoietin(rh-TPO)and eltrombopag are two distinct TPO receptor agonists(TPO-RAs)with different mechanisms.During the pandemic,when immunosuppressive medications are controversial,swit...
Chronic liver disease is characterized by several hematological derangements resulting in a complex and barely rebalanced haemostatic environment.Thrombocytopenia is the most common abnormality observed in these patie...
Supported by the Guangdong Province Medical Science and Technology Research Foundation,No.B2014377;the Medical Scientific Research Project of Foshan,No.20190036.
BACKGROUND Thrombopoietin(TPO)is a primary regulator of thrombopoiesis in physiological conditions.TPO,in combination with its specific cytokine receptor c-Mpl,drives platelet production by inducing the proliferation ...
Supported by the National Research,Development and Innovation Office,No.K-116128;the New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research,Development and Innovation Fund,No.UNKP-20-4-I.
BACKGROUND Colorectal cancer(CRC)is often associated with elevated platelet count(>400×10^(9)/L),known as thrombocytosis.The role of CD40 ligand(CD40L),a member of the tumor necrosis factor family,is controversial in...
A large proportion of patients with chronic hepatitis C have associated thrombocytopenia (TCP). Due to bleeding risks, TCP, when severe, can limit diagnostic and therapeutic procedures, treatments, and increases risk ...
Thrombocytopenia is a multifactorial disorder that is common in patients with chronic liver disease(CLD),leading to challenging perioperative planning.As thrombocytopenia in CLD is associated with thrombopoietin(TPO)d...